See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Recognized by America's Top Doctors, 2015 - 2017
Recognized in Philadelphia magazine's annual Top Docs issues, 2018 - 2020
Penn Medicine Valley Forge
1001 Chesterbrook Boulevard
Berwyn, PA 19312
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Bagley SJ, Kothari S, Aggarwal C, Bauml JM, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, Stonehouse-Lee S, Sherry VE, Gilbert E, Eaby-Sandy B, Mutale F, DiLullo G, Cohen RB, Vachani A, Langer CJ.: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer. 2017 Apr;106:1-7. doi: 10.1016/j.lungcan.2017.01.013. Epub 2017 Jan 25. : 2017.
Thompson JC, Yee SS, Troxel AB, Savitch SL, Fan R, Balli D, Lieberman DB, Morrissette JD, Evans TL, Bauml J, Aggarwal C, Kosteva JA, Alley E, Ciunci C, Cohen RB, Bagley S, Stonehouse-Lee S, Sherry VE, Gilbert E, Langer C, Vachani A, Carpenter EL.: Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA. Clin Cancer Res. 2016 Dec 1;22(23):5772-5782. Epub 2016 Sep 6. : 2016.
Kosteva J, Langer C: The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer. Current Opinion in Oncology 20 (2): 155-161,2008.
Kosteva J, Langer C: Skeletal metastases: Optimal management in 2007. Supportive Care in Cancer Therapy : 2008.
Kosteva J, Langer C: The changing landscape of non-small cell lung cancer: Economic consequences of skeletal metastases. New Directions in the Treatment of Lung Cancer 1 (4): 1-9,2005.
Kosteva J, Langer C.: Skeletal metastases in NSCLC: A retrospective review. 4th Annual ECOG/Aventis Young Investigator Symposium : 2004.
Kosteva J, Langer C: Incidence and distribution of skeletal metastases in NSCLC in the era of PET. Lung Cancer 46 (Suppl 1): S45,2004.
Kosteva J, Langer C: Skeletal metastases of non-small cell lung cancer: Advancements in diagnosis and treatment. Lung Cancer Principles and Practice Updates 4 (2): 1-14,2004.
Abramson Cancer Center at Valley ForgeDivision of Hematology/Oncology1001 Chesterbrook Blvd.
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.